The Salmonella Kinase SteC Targets the MAP Kinase MEK to Regulate the Host Actin Cytoskeleton  by Odendall, Charlotte et al.
Cell Host & Microbe
ArticleThe Salmonella Kinase SteC Targets the MAP Kinase
MEK to Regulate the Host Actin Cytoskeleton
Charlotte Odendall,1,5 Nathalie Rolhion,1 Andreas Fo¨rster,2 John Poh,1,6 Douglas J. Lamont,3 Mei Liu,1 Paul S. Freemont,2
Andrew D. Catling,4 and David W. Holden1,*
1Section of Microbiology, MRC Centre for Molecular Bacteriology and Infection
2Centre for Structural Biology, Division of Molecular Biosciences
Imperial College London, London SW7 2AZ, UK
3FingerPrints Proteomics Facility, College of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, UK
4Department of Pharmacology and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Centre, New Orleans,
LA 70112, USA
5Present address: Division of Gastroenterology, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA
6Present address: Virus Reference Department, HPA Microbiology Services-Colindale, London NW9 5HT, UK
*Correspondence: d.holden@imperial.ac.uk
http://dx.doi.org/10.1016/j.chom.2012.09.011Open access under CC BY license.SUMMARY
After host cell entry, Salmonella replicate in mem-
brane-bound compartments, which accumulate a
dense meshwork of F-actin through the kinase
activity of the Salmonella SPI-2 type III secretion
effector SteC.We find that SteC promotes actin cyto-
skeleton reorganization by activating a signaling
pathway involving the MAP kinases MEK and ERK,
myosin light chain kinase (MLCK) and Myosin IIB.
Specifically, SteC phosphorylates MEK directly on
serine 200 (S200), a previously unstudied phosphor-
ylation site. S200 phosphorylation is predicted to
displace a negative regulatory helix causing auto-
phosphorylation on the known MEK activatory resi-
dues, S218 and S222. In support of this, substitution
of S200 with alanine prevented phosphorylation on
S218 and S222, and phosphomimetic mutations of
S200 stimulated phosphorylation of these residues.
Both steC-null and kinase-deficient mutant strains
displayed enhanced replication in infected cells,
suggesting that SteC manipulates the actin cyto-
skeleton to restrain bacterial growth, thereby regu-
lating virulence.
INTRODUCTION
Salmonella enterica serovar Typhimurium (S. Typhimurium)
causes gastrointestinal disease in humans and a typhoid-like
systemic infection in certain mouse strains. Its virulence requires
two type III secretion systems (T3SSs), encoded by the patho-
genicity islands Salmonella Pathogenicity Island 1 (SPI-1) and
SPI-2. T3SSs are multiprotein organelles assembled in the
bacterial cell envelope with needle-like extensions (Cornelis
and Van Gijsegem, 2000). Effectors proteins translocated by
the SPI-1 T3SS interfere with the actin cytoskeleton to induce
bacterial invasion and contribute to the early maturation of theCell Host &Salmonella-containing vacuole (SCV) (Steele-Mortimer et al.,
2002). The SCV matures into an organelle that has some prop-
erties of late endosomes but lacks degradative enzymes of
lysosomes (Garcia-del Portillo and Finlay, 1995). A few hours
after bacterial entry, the SPI-2 T3SS is activated and delivers
a second set of effector proteins across the vacuolar
membrane. These further modify the SCV and enable intrava-
cuolar bacterial replication (Haraga et al., 2008; Helaine et al.,
2010). In the course of these events, S. Typhimurium causes
major alterations to the microtubule, intermediate filament
(Guignot et al., 2004), and actin (Me´resse et al., 2001; Miao
et al., 2003) networks. Through the action of the SPI-2 T3SS
effector SteC, it induces the formation of a meshwork of F-actin
around SCVs and bacterial microcolonies (Poh et al., 2008).
Although this protein was shown to have kinase activity (Poh
et al., 2008), its target(s) and the physiological significance of
the actin meshwork it forms remained unknown. A previous
study showed that small GTPases of the Rho family, N-WASP,
Scar/WAVE, the Arp2/3 complex, and mDia1, are not involved
in SPI-2-mediated actin reorganization (Unsworth et al., 2004).
Overexpression of SteC in 3T3 fibroblasts induced the formation
of thick F-actin bundles connected to clusters of highly
condensed F-actin (Poh et al., 2008). This stellate appearance
is very similar to that obtained after expression of a constitutively
active mutant of rho-activated kinase (ROCK) (Amano et al.,
1996; Poh et al., 2008), which causes Myosin II activation
through myosin light chain (MLC) phosphorylation (Gallagher
et al., 1991). This suggests that SteC-dependent actin reorga-
nization might involve the formation of F-actin cables through
the action of Myosin II. Here we show that SteC activates
a pathway containing MEK, ERK, myosin light chain kinase
(MLCK), and Myosin IIB. We show that SteC activates MEK1
via a phosphorylation mechanism different to that of endoge-
nous MEK kinases. Deletion of steC or its kinase activity led to
a modest increase in intracellular replication of S. Typhimurium
in epithelial cells and macrophages and bacterial growth in
mice. We conclude that phosphorylation of MEK by SteC
contributes to the formation of the SCV-associated actin mesh-
work and that this could serve to restrain bacterial growth and
regulate bacterial virulence.Microbe 12, 657–668, November 15, 2012 ª2012 Elsevier Inc. 657
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Figure 1. Myosin II Is Recruited to Sites of
SteC-Dependent F-Actin Reorganization in
Its Phosphorylated, Activated Form
(A and B) Swiss 3T3 fibroblasts expressing SteC-
myc (blue) were labeled for Myosin IIB (green in A)
or phospho-myosin light chain (PMLC, green in B)
and stained for F-actin (red). Scale bars represent
40 mm (A) or 20 mm (B).
(C–E) Swiss 3T3 fibroblasts were infected with
different strains of S. Typhimurium (blue) as indi-
cated and were labeled for Myosin IIB (green in C)
or PMLC (green in E) and F-actin (red). Scale bars
represent 8 mm. The percentage of microcolonies
associated with Myosin IIB was quantified in (D).
Results are expressed as means ± SEM of four
independent experiments. **p < 0.01.
See also Figure S1.
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Phosphorylated Myosin IIB Is Recruited
to SteC-Dependent F-Actin Structures
SteC overexpression causes the formation of thick F-actin
fibers connected to clusters of highly condensed F-actin,
similar in appearance to those obtained when Myosin II is
activated (Poh et al., 2008). Three isoforms of the heavy chain
of Myosin II are expressed in nonmuscle cells. Little is known
about Myosin IIC (Buxton et al., 2003; Golomb et al., 2004),
but Myosin IIA and Myosin IIB are well characterized. Myosin
IIA was not detected on SCVs in HeLa cells (Wasylnka et al.,
2008). Since Myosin IIB localizes to a more central region of
nonmotile fibroblasts (Saitoh et al., 1987), we examined the
distribution of the heavy chain of Myosin IIB in Swiss 3T3 cells
expressing SteC. In all cells examined, SteC expression caused
the formation of very thick F-actin bundles to which Myosin IIB
was recruited (Figure 1A). Myosin II molecules are hexamers
composed of heavy-chain dimers and two pairs of light chains.
Phosphorylation of the regulatory MLC induces activation of
the protein complex, and activated Myosin II can bind and
bundle F-actin filaments (Bresnick, 1999). Accordingly, Swiss
3T3 cells were labeled with an antibody recognizing phosphor-
ylated MLC (PMLC). Untransfected, serum-starved cells dis-
played little to no cytosolic PMLC labeling (Figure 1B). In cells
expressing SteC, PMLC labeling was enhanced throughout
the cell and always colocalized with F-actin fibers and clusters
(Figure 1B). Therefore, SteC is sufficient to promote phosphor-
ylation of MLC and its recruitment to SteC-dependent F-actin
bundles.658 Cell Host & Microbe 12, 657–668, November 15, 2012 ª2012 Elsevier Inc.Swiss 3T3 cells were also infected with
different strains of S. Typhimurium and
examined for recruitment of the Myosin
IIB heavy chain to SCVs. In cells infected
for 8 hr with wild-type (WT) or comple-
mented deletion mutant (DsteC, psteC)
strains, approximately 70% of microcolo-
nies were associated with Myosin IIB
(Figures 1C and 1D). In cells infected
with ssaV (SPI-2 T3SS defective) or steC
mutant bacteria, Myosin IIB associationwith SCVs was much lower. The steCmutant translocated other
effectors as efficiently as WT Salmonella (data not shown). This
shows that SteC is responsible for the recruitment of Myosin
IIB to bacterial microcolonies. PMLC colocalized with F-actin
structures around WT S. Typhimurium vacuoles (Figure 1E),
but no PMLC was found in the vicinity of vacuoles containing
steC mutant bacteria, indicating that SteC is also essential for
the recruitment of PMLC to SCVs.
Pharmacological inhibitors were used to investigate whether
Myosin II is involved in SteC-dependent F-actin accumulation.
To avoid prolonged exposure of cells and bacteria to the inhi-
bitors (which could result in nonspecific effects and loss of
inhibitor activity), we pretreated infected cells with the actin-
depolymerizing agent Latrunculin B, which completely prevents
SCV-associated F-actin structures (Unsworth et al., 2004). After
Latrunculin B washout, F-actin accumulates in the vicinity of
vacuoles containing WT but not ssaV (Unsworth et al., 2004) or
steC mutant (data not shown) bacteria. Therefore the Myosin
inhibitors BDM or Blebbistatin were added during Latrunculin
B washout. Exposure of cells to either drug decreased their
ability to accumulate F-actin in the vicinity of SCVs (Figure S1
available online), indicating that Myosin II is involved in the
process of SteC-induced F-actin bundling.
Myosin Isoform Specificity in SteC-Induced F-Actin
Reorganization
To study the requirement of Myosin II isoforms in the formation of
SteC-dependent F-actin meshworks, we usedmouse embryonic
fibroblasts (MEFs) lacking Myosin IIB. These cells and their WT
counterparts do not express Myosin IIC (Lo et al., 2004). Control
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Figure 2. Myosin IIB andMLCKAre Involved
in SteC-Dependent F-Actin Remodeling
RNAi-mediated knockdown of Myosin IIA in WT
or Myosin IIB KO cells (A–C) or of myosin light
chain kinase (MLCK) (D–F).
(A) WT or Myosin IIB KO mouse embryonic fibro-
blasts (MEFs) were transfected with scrambled
(Scr) or Myosin IIA (Myo IIA)-specific pools of
siRNA oligos, as indicated. Myosin IIA and Myosin
IIB levels were assessed by WB. The same blots
were probed for tubulin as a loading control.
(D) Swiss 3T3 fibroblasts were transfected with
a Scr oligo or three individual siRNA oligos against
MLCK (denoted MLCK1, MLCK2, and MLCK3).
Whole-cell lysates were analyzed by WB against
MLCK or tubulin.
(B and E) siRNA-treated cells were infected with
GFP-expressing WT S. Typhimurium (green) and
stained for F-actin (red). Scale bars represent 8mM.
(C and F) Percentage of Salmonella microcolonies
associatedwith F-actin in the conditions indicated.
Results are expressed as means ± SEM of a least
three independent experiments. ***p < 0.001.
See also Figure S2.
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Activation of MEK by Salmonella SteCcells andMyosin IIB knockout (KO) cells were depleted of Myosin
IIA by RNA interference (RNAi)-mediated knockdown (Figure 2A)
and infectedwithWT bacteria for 8 hr. Only cells that were clearly
depleted of Myosin IIA were analyzed. In WT MEFs transfected
with a scrambled small interfering RNA (siRNA) oligo, 75.5% ±
4% of microcolonies were associated with F-actin. Myosin IIA
knockdown inWT cells had no effect on SteC-dependent F-actin
accumulation: 75.4% ± 3% of microcolonies were associated
withF-actin in thesecells (Figures2Band2C).However, inMyosin
IIBKOMEFs, only 44.4%± 2%ofmicrocolonieswere associated
with F-actin (Figure 2C), showing that this isoform contributes
to SteC-dependent F-actin meshwork formation. Since the
inhibition of SteC-dependent F-actin bundling was not complete,
we carried out RNAi of Myosin IIA in these cells, to investigate the
possibility of functional redundancy between the two isoforms.Cell Host & Microbe 12, 657–668, NHowever, there was no additive effect of
Myosin IIA depletion in Myosin IIB KO
cells (Figure 2C). Additionally, embryonic
stem cells lacking Myosin IIA (Even-Ram
et al., 2007) displayed similar levels of
F-actin association as control cells
(data not shown), showing that Myosin
IIB, and not Myosin IIA, is involved in
SteC-dependent F-actin accumulation.
The incomplete reduction in F-actin
association with SCVs in the absence
of Myosin II suggests that SteC also
activates a Myosin-independent pathway
to promote F-actin reorganization.
MLCK, ERK, and MEK Contribute
to SteC-Dependent F-Actin
Structures
MLC phosphorylation and subsequent
Myosin II activation is regulated bynumerous kinases, the best described of which are MLCK and
ROCK (Amano et al., 1996; Kamm and Stull, 1985). We used
the inhibitors ML-7 and Y27632 in the context of Latrunculin B
washouts to investigate whether MLCK and/or ROCK are
involved in SteC-dependent F-actin accumulation. ROCK inhi-
bition had no effect on SteC-dependent F-actin accumulation
(Figure S2A). However, exposure of cells to ML-7 led to a reduc-
tion in SCV-associated F-actin from 73.2% ± 7% in control
cells to 40% ± 1% in treated cells, indicating that MLCK is likely
to be involved in this pathway.
To clarify the roles of MLCK and ROCK in SteC-dependent
F-actin reorganization, we carried out RNAi-mediated knock-
down of these proteins in Swiss 3T3 fibroblasts (Figure S2B;
Figure 2D). Single or combined knockdown of ROCK I and
ROCK II isoforms had no detectable effect on SteC-dependentovember 15, 2012 ª2012 Elsevier Inc. 659
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Figure 3. MEK and ERK Contribute to
F-Actin Meshwork Formation
(A–C) WT MEFs were depleted of ERK1 and ERK2
with a mixture of siRNA oligos. Cells were infected
with GFP-expressing S. Typhimurium (green in C),
stained for F-actin (red) and scored for F-actin
association with microcolonies (B).
(D–F) Similarly, WT or MEK-1 KO MEFs were
transfected with a scrambled (Scr) oligo or three
individual MEK2-targeting siRNAs (denoted
MEK2-1, MEK2-2, and MEK2-3) as indicated (D).
Cells were infected with Salmonella (green in F)
and stained for F-actin (red), and F-actin associa-
tion with microcolonies was quantified (E).
(G and H) MEFs depleted of ERK1/2 or MEK1/2
were infected for 8 hr with WT S. Typhimurium
(blue in H) and were labeled for Myosin IIB
(green) and stained for F-actin (red). Myosin IIB
recruitment to Salmonella microcolonies was
quantified (G).
Results are expressed as means ± SEM of three
independent experiments (B, E, and G). Scale bars
represent 8 mm (C, F, and H). *p < 0.05, **p < 0.01,
***p < 0.001. See also Figure S3.
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Activation of MEK by Salmonella SteCF-actin reorganization (Figure S2C). However, depletion of
MLCK with three individual oligos reduced F-actin accumula-
tion around microcolonies by approximately 50% (Figures 2E
and 2F; Figure S2C), confirming a role for MLCK in this process.
MLCK is activated upon Ca2+/calmodulin binding, and this
activation was shown to be enhanced by ERK-mediated phos-
phorylation (Klemke et al., 1997). As the amino acid sequence
of SteC displays similarity to that of C-Raf (Poh et al., 2008),
a member of the Raf/MEK/ERK MAP kinase pathway (Seger
and Krebs, 1995), the roles of MEK and ERK in SteC-dependent
F-actin reorganization were investigated.
Swiss 3T3 cells were infected with WT S. Typhimurium and
subjected to Latrunculin B washouts in the presence of MEK1/
2 (PD98059) or ERK (FR180204) inhibitors. Both inhibitors sig-
nificantly reduced the percentage of microcolonies associated
with F-actin (Figures S3A and S3B). The involvement of these
proteins was also investigated with siRNA. Efficient depletion
of ERK1 and ERK2 (Figure 3A) led to a decrease in the
percentage of SCV-associated F-actin from 76.4% ± 7% to660 Cell Host & Microbe 12, 657–668, November 15, 2012 ª2012 Elsevier Inc.43.2% ± 3% (Figures 3B and 3C). To
deplete cells of both MEK isoforms, we
subjected MEK2 to siRNA in WT and
MEK1 KO fibroblasts (Figure 3D). RNAi-
mediated knockdown of MEK2 in WT
cells caused a very limited reduction in
SCV-associated F-actin compared to
cells transfected with a scrambled siRNA
oligo (Figures 3E and 3F), and microcolo-
nies remained associated with F-actin in
MEK1 KO cells. However RNAi of MEK2
in MEK1 KO fibroblasts led to a signifi-
cant decrease in SCV association with
F-actin (Figures 3E and 3F). Together,
these results show that MEK and ERK
are involved in SteC-dependent F-actinassembly and that MEK1 and MEK2 are functionally redundant
in this pathway.
The experiments above indicate that MEK, ERK, MLCK, and
Myosin II each contribute partially to SCV-associated F-actin.
To study whether MEK, ERK, and Myosin are in the same SteC-
induced pathway, we examined SCV-associated Myosin IIB in
cells depleted of ERK1/2 or MEK1/2. There was a strong reduc-
tion of Myosin IIB recruitment to microcolonies in cells lacking
theseproteins (Figures 3Gand3H). In addition, exposure of fibro-
blasts expressing SteC to inhibitors of MEK or MLCK prevented
phosphorylation ofMyosin and completely blocked the formation
of SteC-induced F-actin fibers. However, some SteC-dependent
F-actin-rich structures remained (indicated by arrowheads in Fig-
ure S3C). Evidently, SteC-induced F-actin meshwork formation
involves one pathway requiring MEK, ERK, MLCK, and Myosin
II and a second pathway that is independent of these proteins.
Next we investigated whether a Raf isoform might be involved
in SteC-induced F-actin structures. RNAi of B-Raf and C-Raf
was carried out in Swiss 3T3 fibroblasts (Figure S4A), which
Cell Host & Microbe
Activation of MEK by Salmonella SteCwere then infected with WT S. Typhimurium. Although both iso-
forms could be effectively depleted singly or in combination (Fig-
ure S4A), a similar proportion of microcolonies was associated
with F-actin in knocked down and control cells, indicating that
neither isoform is involved in this process (Figures S4B and S4C).
SteC Promotes MEK and ERK Phosphorylation
To examine SteC-dependent phosphorylation of MEK during
bacterial infection, we infected Swiss 3T3 fibroblasts with
different strains of S. Typhimurium for 8 hr and subjected lysates
to immunoblotting with an antibody recognizing MEK1 and
MEK2 phosphorylated on the two activatory residues: S218
and S222. Infection with WT bacteria greatly increased the
levels of phosphorylated MEK, in an SteC-dependent manner
(Figure 4A, top panel, compare lanes 2 and 3). Expression of
SteC in the steC mutant strain restored MEK phosphorylation.
This was kinase dependent since infection with the DsteC,
psteCK256H (kinase dead) (Poh et al., 2008) strain did not
restore the ability of the steC mutant strain to phosphorylate
MEK (Figure 4A, top panel, lanes 4 and 5). ERK phosphorylation
was tested with an antibody recognizing both ERK1 and ERK2
phosphorylated on the MEK target sequence. As for MEK, ERK
was phosphorylated by infection with WT bacteria in an SteC-
and SteCK256-dependent manner (Figure 4A, lower panels).
Furthermore, cells depleted of both MEK1 and MEK2 had
much reduced Salmonella-induced ERK phosphorylation (Fig-
ure 4B). Taken together, these results show that SteC induces
the phosphorylation of MEK and subsequent ERK phosphoryla-
tion in infected cells.
The similarity between the kinase domain of SteC and C-Raf
(Poh et al., 2008) suggested that SteC might mimic C-Raf func-
tion and phosphorylate MEK directly. To test this, we purified
SteC and the kinase-dead mutant SteCK256H as 6-Histidine
(His) fusion proteins. These were incubated with [g-32P] ATP
and purified WT MEK1. Proteins were then separated by
SDS-PAGE and analyzed by autoradiography. SteC underwent
autophosphorylation as described previously (Poh et al., 2008).
Whereas SteCK256H was unable to autophosphorylate or
phosphorylate MEK1 (Figure 4C), 32P was incorporated into
MEK1 following incubation with SteC, showing that MEK1 is
directly phosphorylated by SteC in vitro (Figure 4C).
Phosphorylation of MEK1 by SteC was then analyzed bymass
spectrometry with precursor ion scanning. Phosphorylation of
either S218 or S222 was revealed by the presence of a weakly
assigned phosphopeptide. However, a combination of precursor
ion scanning and titanium dioxide enrichment clearly revealed
phosphorylation of S200 (Figure 4D). This residue is conserved
in both MEK1 and MEK2 of mammalian species, as well as in
Ste7 in Saccharomyces cerevisiae (data not shown).
SteC Induces MEK1 Autophosphorylation
Structural analysis of MEK revealed that amino acids 32–51 fold
into an alpha helix (helix A) that is packed against the N-terminal
lobe and the MEK1 kinase domain and maintains MEK1 in an
inactive state (Fischmann et al., 2009; Mansour et al., 1996;
Ohren et al., 2004). S200 is part of a loop that forms critical
interactions with the helix: R49 on helix A interacts with R201
(Figure S5), the interaction being further stabilized by E203
(Fischmann et al., 2009). Mutations of residues 47–49 or 203Cell Host &increase MEK1 activity (Delaney et al., 2002; Mansour et al.,
1996). Therefore, the interaction between these residues is
important for the packing of helix A against the MEK1 kinase
domain, and disruption of these interactions induces MEK1
activation. To investigate whether addition of a negative phos-
phate group on S200 by SteC might alter these interactions,
we carried out molecular dynamics analyses using the unmodi-
fied protein (native), MEK1 phosphorylated in silico at position
S200, or on the consensus regulatory residues S218/222. While
the whole-protein geometry remained largely unchanged over
time, important changes occurred in two specific regions of
the protein, helix A and the T loop. The stacking interaction
between R49 and R201 was broken in MEK1 phosphorylated
on S200 (Figure S5). This caused a displacement of helix A (Fig-
ure 5A) measured by an increase from 12.9 A˚ to 16.9 A˚ between
the alpha carbons of R49 and R201 (Figure 5B; Figure S5).
In native MEK1, the T loop carrying the two activatory resi-
dues, S218 and S222, had a poorly defined conformation and
appeared flexible (Figure 5C). When both S218 and S222 were
phosphorylated, the T loop peptide backbone assumed a helical
conformation in which the serine residues were largely fixed in
space. Strikingly, S200 phosphorylation appeared to induce
a similar, rigid T loop structure with S218 and S222 in a short
helix. Therefore, S200A partially mimicked the conformational
change brought onto the T loop upon direct phosphorylation of
S218/222.
Helix A displacement was previously shown to induce MEK1
activation, in part by inducing autophosphorylation on S218/
222 (Mansour et al., 1996). Since S200 phosphorylation is pre-
dicted to induce a conformational change in the T loop, we
hypothesized that this might favor autophosphorylation on
S218/222. To test this, the ability of SteC to cause phosphoryla-
tion of MEK1 on S218/222 was examined in an in vitro kinase
assay. Total phosphorylation of MEK1 by SteC was assessed
by autoradiography after incubation of the proteins in the pres-
ence of radiolabeled ATP. As described above, SteC but not
kinase-dead SteCK256H induced MEK1 phosphorylation (Fig-
ure 5D, middle panel). Use of a phosphospecific antibody for
S218/222 showed that SteC induced MEK1 phosphorylation on
S218/222 (Figure 5D, bottom panel, lane 1). To test whether
this could occur indirectly throughautophosphorylation,we incu-
bated SteC with kinase-inactive MEK1 (MEK1K97R, Figure 5D,
lane 2). Total phosphorylation of MEK1K97R by SteC was
observed, but levels were repeatedly very low when compared
to phosphorylation of WT MEK1 (Figure 5D, middle panel, lanes
1 and 2). However, phosphorylation of MEK1K97R on S218/222
was never observed (Figure 5D, bottom panel, lane 2). These
results suggest that SteC requiresMEK1 kinase activity to induce
phosphorylation on S218/222 and that SteC might activate
MEK1 by inducing its autophosphorylation on the T loop serines.
To determine whether S200 is necessary for SteC-mediated
MEK1 autophosphorylation, we used retroviral gene transfer of
MEK1 KO MEFs to create cell lines expressing similar levels of
WT MEK1 or a point mutant of MEK1 in which S200 was
substituted with alanine (S200A). WT MEK1 and MEK1 S200A
were immunoprecipitated and subjected to in vitro kinase
assays in the presence of recombinant His-SteC. Whereas
SteC caused phosphorylation of S218/222 of WT MEK, it was
unable to induce efficient phosphorylation of S218/222 inMicrobe 12, 657–668, November 15, 2012 ª2012 Elsevier Inc. 661
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Figure 4. Phosphorylation of MEK1 by SteC
(A) Swiss 3T3 fibroblasts were infected with the indicated strains of S. Typhimurium (S. T) for 8 hr. Cells were then lysed and MEK1/2 or ERK1/2 phosphorylation
was assessed by WB with antibodies specific for MEK1/2 phosphorylated on S218/S222 or ERK phosphorylated at the MEK (T202/T204) consensus site. Total
MEK or ERK levels were assessed as loading controls.
(B) WT or MEK1 KOMEFs were transfected with scrambled (Scr) or MEK2-targeting siRNA oligos. Cells were then infected with WT S. Typhimurium for 8 hr and
ERK phosphorylation was measured as described above.
(C) MEK1 was incubated with SteC or SteCK256H in kinase assay buffer with [g-32P] ATP at 30C for 30 min. Proteins were subjected to SDS-PAGE followed
by Coomassie blue staining and autoradiography.
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Activation of MEK by Salmonella SteCMEK1S200A (Figure 5E) (p < 0.05). This shows that S200 is
important for SteC-mediated MEK1 autophosphorylation on its
activatory residues.
To further characterize S200-mediatedMEK1 autophosphory-
lation, we created MEK1 phosphomimetic mutants by sub-
stituting S200 with aspartic acid (S200D) or glutamic acid
(S200E). These constructs were expressed in serum-starved
REF52 fibroblasts (Park et al., 2007). Cells were then incubated
in 0.1%, 3%, or 10% FCS for 10 min (Figure 5F). Ectopically
expressed MEK1 proteins were immunoprecipitated and S218/
222 phosphorylation was assessed by immunoblotting. WT
MEK1 displayed modest S218/222 phosphorylation upon serum
stimulation. By contrast, the S200D or S200E mutants displayed
stronger S218/222 phosphorylation in presence of 3% or 10%
serum. Therefore, mimicking S200 phosphorylation by SteC
potentiates conventional phosphorylation of MEK1 on S218/
222. However, since the phosphomimetic mutants did not
stimulate S218/222 phosphorylation in the absence of serum,
we conclude that phosphorylation of S200 is necessary but not
sufficient for SteC-induced activation of MEK.
SteC Controls Intracellular Replication
of S. Typhimurium
Previous work failed to reveal a virulence defect of the steC
mutant strain in the mouse model of systemic infection (Poh
et al., 2008). To reassess the possibility of an effect of SteC on
virulence, we inoculated mice by the oral route with a mixed
inoculum comprising equivalent numbers ofWT and steCmutant
bacteria and compared their growth after 4 days by competitive
index (CI) analysis, which provides a sensitive measure of the
relative degree of attenuation (Beuzo´n and Holden, 2001). The
steCmutant had amean CI of 4.33 ± 1.1, showing that its growth
in vivo was greater than that of the WT strain. This is consistent
with results obtained elsewhere (Geddes et al., 2007). As
S. Typhimurium replicates poorly in fibroblasts (Cano et al.,
2001), we measured its growth in both epithelial cells and
macrophages. After 12 hr in HeLa cells, there were approxi-
mately twice as many WT as ssaV mutant bacteria (Figure 6A).
Similar results were obtained in mouse bone marrow (BM)-
derived macrophages (Figure 6B). Interestingly, there was a
significantly greater number of steC mutant bacteria compared
toWT andDsteC, psteC bacteria after both 8 hr and 12 hr growth
in HeLa cells and after 24 hr in BM macrophages (Figures 6A
and 6B). The DsteC, psteCK256H mutant also displayed
increased intracellular growth, showing that this effect was
dependent on the kinase activity of SteC.
DISCUSSION
To date, approximately 28 effectors translocated by the
Salmonella SPI-2 T3SS have been identified (Figueira and(D) Phosphorylation site identification of MEK phosphopeptide DVKPSNILVNSRG
used in conjunction with MS-Product (ProteinProspector v 5.7.2) to annotate bo
phosphorylation (denoted by S). The y1 ion indicates that the peptide has a Lys (
the peptide, Asp-Val-Lys (D-V-K). The loss of phosphoric acid (MH-H3PO43+)
phorylated and the site of phosphorylation is confirmed by the ions b6/b7 and y7
cps, counts per second.
See also Figure S4.
Cell Host &Holden, 2012), but the biochemical activities and physiological
functions of most remain to be established. In this paper, we
describe a signaling pathway activated by the SPI-2 T3SS
effector SteC to promote the formation of host cell F-actin
structures that accumulate close to SCVs in infected cells. Using
a variety of different approaches, we show that SteC activates
a pathway involving MEK, ERK, MLCK, and Myosin IIB (Fig-
ure 6C). We found that SteC activates MEK in a noncanonical
manner by phosphorylating a previously unstudied residue,
which is predicted to cause the displacement of an inhibitory
helix and autophosphorylation of MEK1 on its activatory resi-
dues. In addition, we have shown that SteC acts to restrain
bacterial growth in infected cells and in mice.
Whereas the Raf/MEK/ERK signaling pathway is well studied
in relation to cell proliferation, apoptosis, differentiation, and
immune responses (Shaul and Seger, 2007), its involvement
in cytoskeletal dynamics is less well understood, even though
there is increasing evidence that MEK/ERK regulate focal adhe-
sion dynamics and promote cell migration (Anand-Apte et al.,
1997; Brahmbhatt and Klemke, 2003; Fincham et al., 2000;
Klemke et al., 1997; Lai et al., 2001; Nguyen et al., 1999; Webb
et al., 2001). In particular, ERK was shown to phosphorylate
MLCK directly, increasing its capacity to phosphorylate MLC
and activate Myosin II to promote cell migration (Klemke et al.,
1997; Morrison et al., 1996). The work presented here provides
additional evidence for a role of MEK and ERK in cytoskeletal
dynamics, and for the MEK/ERK/MLCK/Myosin II pathway.
This pathway has not been shown previously to be targeted by
bacterial pathogens. However, several other virulence factors—
including Salmonella SPI-1 and SPI-2 T3SS effectors—manipu-
late individual components of the MEK/ERK/MLCK/Myosin II
pathway. For example, the SPI-1 effector SopB was shown to
target Myosin II to facilitate both Salmonella entry into cells
(Ha¨nisch et al., 2011) and positioning in the perinuclear region
(Wasylnka et al., 2008). However, in both cases SopB activates
Myosin II via a pathway that involves the small GTPase Rho
and its effector ROCK. Although SteC also modulates Myosin
II activity, it is highly unlikely to be involved in the above
processes. First, translocation of SteC was first detected 4 hr
after S. Typhimurium entry (Poh et al., 2008), and second, loss
of SteC does not affect the localization of SCVs in host cells
(data not shown). In addition, SopB, together with the SPI-1
effectors SopE and SopE2, induces the phosphorylation of
ERK, causing intestinal inflammation (Bruno et al., 2009). ERK
is also negatively regulated by the SPI-2 T3SS effector SpvC
(Mazurkiewicz et al., 2008), a phosphothreonine lyase that was
shown to dephosphorylate ERK and other MAP kinases. Inter-
estingly, SpvC was only detected in infected cells 16 hr after
entry. This is of interest as SCV-associated F-actin structures
are no longer detectable after 18 hr of infection (Brumell et al.,
2002). This has been attributed to SpvB (encoded within theEIK. Tandem mass spectrum obtained for precursor ion at m/z 617.2803+ was
th C-terminal (y) ions and N-terminal (b) ions present and confirm the site of
K) residue at its C terminus and the b2/b3 ions correlate with the N terminus of
from the triply charged precursor (MH3+) indicates that the peptide is phos-
-H3PO4 and y8-H3PO4. m/z, mass to charge ratio in atomic mass units (amu);
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Figure 5. MEK1 Phosphorylation on S200 Induces Helix A Displacement and Autophosphorylation on S218/222
(A–C) Molecular dynamics (MD) simulations were carried out on native MEK1 (cyan), MEK1 phosphorylated on S218/222 (magenta), or MEK1 phosphorylated on
S200 (salmon). All snapshots were taken at 35.6 ns. (A) Superposition of three snapshots showing helix A displacement when S200 is phosphorylated. Helix A
was excluded for the calculation of the superposition. (B) Separation between the alpha carbon atoms of R49 and R201 over the course of the simulation. (C)
Cartoon representation of the region around the T loop. S218, S222 and ATP are shown as sticks, Mg2+ as a white sphere. In the middle panel, two stabilizing Na+
ions are shown as yellow spheres.
(D) MEK1 or MEK1K97R were incubated with SteC or SteCK256H in kinase assay buffer with [g-32P] ATP at 30C for 30 min. Proteins were subjected
to SDS-PAGE followed by Coomassie blue staining and autoradiography or WB with a phospho-specific antibody against MEK1 phosphorylated on S218
and S222.
(E) MEK1 variants were immunoprecipitated from MEK1 KO cells expressing MEK1-Flag (MEK1-WT) or MEK1 S200A-Flag. Cells containing no transgene (KO)
were used as a control. IPmixtures were incubated with recombinant SteC-His in kinase assay buffer at 30C for 30min. MEK1 phosphorylation on S218/222 was
assessed by WB. The membrane was reprobed with anti-Flag and anti-His antibodies as loading controls.
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lates actin and inhibits the formation of SCV-associated actin
structures (Miao et al., 2003), but it is possible that SpvC also
contributes to this process by reversing SteC-dependent ERK
phosphorylation.
MEK1 is known to autophosphorylate or be phosphorylated
by Raf, MEKK, and Mos on two serines found on the T loop:
S218 and S222 (Alessi et al., 1994). This is predicted to cause
the rotation of the N-proximal lobe and the C-proximal lobes
with respect to each other, closing the catalytic cleft. This is
accompanied by stabilization of interactions between the activa-
tory loop and active site residues, optimizing the orientation of
residues required for ATP binding and catalysis of the g phos-
phate of ATP onto the target protein (Cox et al., 1994; Goldsmith
and Cobb, 1994; Johnson et al., 1996). Our evidence suggests
that unlike Raf, SteC activates MEK1 indirectly, by inducing
its autophosphorylation on S218/222. This is reminiscent of
PAK1-mediated activation of MEK1: PAK1 was shown to phos-
phorylate MEK1 on S298, causing its autophosphorylation on
S218/222 (Park et al., 2007). However, SteC phosphorylates
MEK on S200. This residue is part of a loop that contains R201
and E203, which interact with R49 on helix A (Fischmann et al.,
2009). This is of particular interest as helix A was previously
shown to inhibit MEK1 by packing onto the kinase domain (Man-
sour et al., 1996). In agreement with this, deletions of residues
within the helix, or substitution of E203 stimulated MEK1 activity
by several orders of magnitude (Delaney et al., 2002; Mansour
et al., 1996). Molecular dynamics analyses revealed that phos-
phorylation of MEK1 on S200 caused helix A to move away
from the rest of protein, which is predicted to derepress MEK1
activity. It also induced a conformational change to the T loop
carrying S218/222, even though this loop is situated 30 A˚ away
from S200. We propose that S200 phosphorylation leads to
S218/222 autophosphorylation by inducing two conformational
changes: the displacement of helix A and the repositioning of
the T loop. Although substitution of S200 with an alanine residue
prevented efficient activation of MEK by SteC, phosphomimetic
substitutions only stimulated phosphorylation on S218/222 in
the presence of serum after starvation. Therefore, phosphory-
lation of S200 is necessary but unlikely to be sufficient for
SteC-induced activation of MEK. Furthermore, inhibition and
absence of some of the proteins in the MEK/ERK/MLCK/Myosin
II pathway only reduced SCV-associated F-actin by approxi-
mately 50%. This suggests the existence of an actin reorganiza-
tion activity of SteC that is independent of the Myosin pathway
reported here. It is possible that other effectors exist that are
dependent on SteC and modulate the actin cytoskeleton inde-
pendently of the Myosin pathway.
It is becoming clear that while the majority of Salmonella viru-
lence proteins that interfere with host cell functions promote
bacterial growth, others appear to restrain its proliferation
(Baek et al., 2009; Gal-Mor et al., 2008; Ho and Slauch, 2001).
SteC seems to belong to the second category. The rate of intra-(F) REF52 cells expressing HA-MEK1, HA-MEK1 S200D, or HA-MEK1 S200E were
were added to the growth medium for 10 min. MEK proteins were immunoprec
S218/222 by WB. Membranes were reprobed with an HA antibody, as a loading
See also to Figure S5.
Cell Host &cellular bacterial growth appears to be a tightly controlled
process involving a balance between the activity of replication-
promoting and replication-restraining virulence proteins.
How the kinase activity of SteC functions to modulate intracel-
lular growth of Salmonella is unknown, but several possibilities
can be envisaged. First, it has been shown that in macrophages,
S. Typhimurium activates MEK to restrain bacterial growth
(Rosenberger and Finlay, 2002), while other studies have re-
ported that it induces ERK-dependent IL-10 production (Uchiya
et al., 2004; Uchiya andNikai, 2004) and inhibits proinflammatory
cytokine production (Uchiya and Nikai, 2005). It is possible that
the kinase activity of SteC contributes to these phenomena.
Second, it is likely that the SteC-driven recruitment of Myosin II
and F-actin to SCVs interferes with normal vesicular traffic and
fusion events in the host cell. Myosin II is required for vesicle
biogenesis at the Golgi (Ikonen et al., 1997; Miserey-Lenkei
et al., 2010), and actin and myosins are involved in short-range
movement and fusion of vesicles with late endocytic organelles
(Kjeken et al., 2004). Since SCVs interact with both endocytic
(Me´resse et al., 1999) and Golgi-derived (Mota et al., 2009) vesi-
cles, the reorganization of Myosin II and F-actin could influence
SCV maturation and bacterial growth. Third, SteC-mediated
activation of MEK and ERK is likely to have consequences
beyond cytokine production and actin reorganization, since
these proteins affect many cellular processes. Further work is
required to clarify the function of this interesting protein in
restraining growth of S. Typhimurium in host cells.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Growth Conditions
The bacterial strains used in this study are listed in Table S1. Bacteria were
grown in Luria Bertani medium (LB) at 37C in an orbital shaker. Where appro-
priate, LB was supplemented with 50 mg/ml carbencillin (Cb) or 50 mg/ml
kanamycin (Km). The plasmids used in this study are listed in Table S2.
Plasmids were purified with a QIAfilter plasmid midi or mini kit (QIAGEN).
Site-directed mutagenesis was done as described in the Supplemental Exper-
imental Procedures.
Antibodies
A list of primary antibodies used in this study is shown in Table S3. AMCA-,
Cy2-, Cy5-, or Rhodamine red X (RRX)-conjugated donkey anti-goat, anti-
rabbit, or anti-mouse antibodies (Jackson Immunoresearch Laboratories)
were used for immunofluorescence (IF) at a dilution of 1:200. RRX-conjugated
phalloidin was purchased from Molecular Probes and used at a dilution of
1:100. Anti-mouse, anti-goat, anti-rabbit, and anti-rat (IgG) horseradish perox-
idase-conjugated secondary antibodies (Amersham Pharmacia Biosciences)
were used at a dilution of 1:10,000 for western immunoblotting (WB) analysis.
Cell Culture, Transfection, and Retroviral Gene Transfer
Please refer to the Supplemental Experimental Procedures.
Bacterial Infection of Cells, Immunofluorescence Microscopy,
and Replication Assays
HeLa cells, MEFs, and Swiss 3T3 fibroblasts were infected with exponential
phase S. Typhimurium as described previously (Beuzo´n et al., 2000). Forserum starved for 16 hr. The indicated concentrations of fetal calf serum (FCS)
ipitated with an anti-HA antibody and assessed for their phosphorylation on
control.
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Figure 6. SteC Controls Salmonella Replication
(A and B) HeLa cells (A) or bone marrow (BM)-derived macrophages (B) were
infected with the indicated S. Typhimurium strains. At the time points indi-
cated, cells were lysed, and released bacteria were grown on rich medium for
enumeration of colony-forming units (cfu). Values of fold increase in bacterial
numbers were calculated from the ratio of the numbers of cfu/ml at each time
point, and the number of intracellular bacteria at 2 hr after entry. Results are
expressed as mean fold increase ± SEM of at least three independent
experiments. *p < 0.05.
(C) Model of SteC-dependent F-actin reorganization: SteC activates MEK
through phosphorylation of S200, causing displacement of helix A and auto-
phosphorylation on S218/222. MEK1 phosphorylation leads to the activation
of a signal transduction pathway involving ERK, MLCK, and Myosin IIB to
induce cytoskeletal rearrangements in the vicinity of Salmonella micro-
colonies. SteC also induces a Myosin-independent signaling pathway to
remodel the actin cytoskeleton.
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opsonization in mouse serum for 20 min, bacteria were added to the cells at
a multiplicity of infection of 10:1, centrifuged at 110 3 g for 5 min, and incu-
bated at 37C for 25 min. So that a synchronized population of bacteria could
be followed, extracellular bacteria were killed through washing of the host cells
with DMEM containing 100 mg/ml gentamicin for 1 hr. The concentration of
gentamicin was then decreased to 20 mg/ml for the remainder of the experi-
ment. For enumeration of intracellular bacteria, infected cells were washed
three times with PBS and lysed with 0.1% Triton X-100 for 5 min, and dilution
series were plated onto LB agar. All inhibitors were purchased from
Calbiochem. In experiments involving Latrunculin B washouts, 4 hr after
invasion, infected cells were incubated Latrunculin B (1 mg/ml) for 4 hr. They
were then washed thoroughly with fresh medium and incubated with ML-7,
Y27632, PD98059 (30 mM), FR180204 (20 mM), BDM (5 mM), or Blebbistatin
(25 mM) for 30 min. For IF, cells were fixed in paraformaldehyde, permeabilized
in 0.1% saponin, and incubated with antibodies as described (Beuzo´n et al.,
2000). Labeled cells were analyzed with a Zeiss confocal laser scanning
microscope (LSM510) or a Nikon T-2000 inverted spinning disc confocal
microscope (Yokogawa).
Protein Purification and Kinase Assays
SteC-6His and SteCK256H-6His were expressed and purified as described
before (Poh et al., 2008). Protein samples were dialysed in 40 mM Tris-Cl
(pH 7.4) overnight and used for kinase assays. For assays with recombinant
MEK proteins, 1 mg purified SteC-6His or SteCK256H-6His was incubated
with 1 mg MEK1 or MEK1K97R (Upstate). Assays were carried out in 50 mM
Tris-Cl (pH 7.5), 10 mMMgCl2, 100mMNaCl, and 1mMdithiothreitol. In radio-
active assays, 20 mM ATP and 2 mCi [g32P] ATP (Amersham, 370 MBq ml1,
3000 Ci mmol1) were added, or 1 mM ATP was used in cold assays. The
mixture was incubated for 30 min at 30C and subjected to SDS-PAGE,
Coomassie blue staining, and autoradiography or WB with phospho-specific
antibodies. Alternatively, MEK1 KO cells transduced with vectors encoding
MEK1-Flag or MEK1-S200A-Flag were lysed in modified RIPA buffer (50 mM
Tris-Cl, 250 mM NaCl, 0.25% Sodium deoxycholate, 1% NP-40, 1 mM
Na3VO4, 1 mM NaF, and Complete EDTA-containing protease inhibitor).
MEK1 variants were immunoprecipitated with agarose-conjugated mouse
anti-Flag antibody (M2, Sigma). Kinase assays were carried out as described
above, directly on the beads.
Cell Lysis and Western Blotting
Swiss 3T3 cells or MEFs were collected from a well in a 6-well plate 3 days
after transfection with siRNAs. Infected Swiss 3T3 cells were collected 8 hr
after invasion. Cells were lifted with trypsin and washed in PBS before lysis
in 53 sample buffer (0.25 M Tris-Cl [pH 6.8], 10% SDS, 10% b-Mercaptoetha-
nol, 10% glycerol, and 0.05% Bromophenol Blue) supplemented with 2 mM
activated Na3VO4 and 10 mM NaF. Samples were boiled for 5 min and sepa-
rated by SDS-PAGE. Samples were then transferred onto PVDF Immobilon-P
membranes (Millipore), and WB was carried out according to the manufac-
turer’s instructions. Animal procedures were conducted in accordance with
UK Home Office Guidelines.
Competitive Index Assay
Female BALB/c mice (B and K Universal, Hull, UK) of 18–22 g were inoculated
by oral gavage with bacteria suspended in physiological saline solution. The
bacterial inocula used were 1 3 108 cfu of each strain in 0.2 ml. At least five
mice were inoculated per strain mixture for each experiment. Mice were sacri-
ficed 4 days after inoculation. The CI value is the mean of three independent
experiments.
Mass Spectrometry and Molecular Dynamics Analysis
Please refer to the Supplemental Experimental Procedures.
Statistical Analyses
All results are reported as mean ± standard error of the mean (SEM). Statistical
analyses were performed with Prism 5 software (GraphPad) with one-way
ANOVA and Bonferroni post hoc analyses or two-tailed unpaired Student’s
t test. Differences denoted as significant in the text fall below a p value of 0.05.evier Inc.
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